<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03842930</url>
  </required_header>
  <id_info>
    <org_study_id>CIP_18/002</org_study_id>
    <nct_id>NCT03842930</nct_id>
  </id_info>
  <brief_title>ELECT Trial - Embolization of the Lumbar Arteries Before EVAR</brief_title>
  <official_title>Embolization of the Lumbar Arteries Before EVAR: A Prospectively Randomized Trial Comparing Platinum-Fibered Microcoils (Control Arm) With the MVP® Microvascular Plug (Study Arm)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Leipzig</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Leipzig</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Prospective, Randomized, Single-center Study for the Treatment of Subjects with Abdominal
      Aortic Aneurysm: Embolization of the Lumbar Arteries Before EVAR: A Prospectively Randomized
      Trial Comparing Platinum-Fibered Microcoils (control arm) with the MVP® Microvascular Plug
      (study arm)&quot;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study is a prospective, single-center, 1:1 randomized trial to investigate the
      difference in radiation dose and intervention time between the embolization with FCP and
      MVP-Plug.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 1, 2019</start_date>
  <completion_date type="Anticipated">February 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">August 1, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Radiation dose for embolization of the lumbar arteries with the MVP plug or coils</measure>
    <time_frame>through study completion, an average of 3-4 month</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Intervention time for embolization of the lumbar arteries with the MVP plug or coils</measure>
    <time_frame>through study completion, an average of 3-4 month</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Success in complete occlusion of the targeted lumbar artery</measure>
    <time_frame>through study completion, an average of 3-4 month</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Aortic Aneurysm</condition>
  <arm_group>
    <arm_group_label>Platinum-fibered Microcoils (FPC)</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Embolization using platinum fibred Coils (Cook Incorporated, Bloomington, IN, USA)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>MVP® Vascular Plug</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Embolization using MVP®-Plug (Medtronic Inc., Minneapolis, MI, USA).</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Endovascular embolization</intervention_name>
    <description>Endovascular embolization of the Lumbar Arteries</description>
    <arm_group_label>MVP® Vascular Plug</arm_group_label>
    <arm_group_label>Platinum-fibered Microcoils (FPC)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Subject age ≥ 18

          2. Subject has been informed of the nature of the study, agrees to participate, and has
             signed a Medical Ethics Committee approved consent form.

          3. Indication for the occlusion of lumbar arteries due to:

               1. Subject has an abdominal aortic aneurysm and

               2. At least 2 patent lumbar arteries in the diseased area

          4. Subject understands the duration of the study, agrees to attend the stentgraft
             implantation

          5. A microcatheter is successfully placed the target lumbar artery.

        Exclusion Criteria:

          1. Any surgical procedure or intervention performed within 30 days prior to or post index
             procedure

          2. Aortic aneurysm requires treatment with alternative therapies such as operation

          3. any other aortic pathology

          4. major untreated cardio-pulmonary disease

          5. life-expectancy of less than one year

          6. expected lack of compliance (e.g. if the patient may not be willing to have several
             sessions and the following repair done)

          7. pregnant or nursing women

          8. impaired thyroid function, if not under stable treatment

          9. women of child-bearing potential without highly effective contraceptive measures

         10. Enrolled in another investigational drug, device or biologic study

         11. Failure to successfully intubate an lumbar artery

         12. Stroke or heart attack within 3 months prior to enrollment

         13. Known allergies or sensitivity to heparin, aspirin, other anticoagulant/ antiplatelet
             therapies, paclitaxel or contrast media that cannot be adequately pre-treated prior to
             index procedure

         14. Significant gastrointestinal bleeding or any coagulopathy that would contraindicate
             the use of anti-platelet therapy.

         15. Platelet count &lt;100,000 mm3 or &gt;600,000 mm3

         16. Receiving dialysis or immunosuppressant therapy

         17. Chronic kidney disease (serum creatinine &gt; 2.5 mg/dL)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dierk Scheinert, Prof. Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Clinic Leipzig</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Dierk Scheinert, Prof. Dr. med.</last_name>
    <phone>+49 341 97</phone>
    <phone_ext>18770</phone_ext>
    <email>dierk.scheinert@medizin.uni-leipzig.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Janin Lenzer</last_name>
    <phone>+49 341 97</phone>
    <phone_ext>18774</phone_ext>
    <email>janin.lenzer@medizin.uni.leipzig.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University Clinic Leipzig</name>
      <address>
        <city>Leipzig</city>
        <state>Saxony</state>
        <zip>04103</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Manuela Matschuck, Prof.</last_name>
      <phone>+49-341-97</phone>
      <phone_ext>18774</phone_ext>
      <email>manuela.matschuck@medizin.uni-leipzig.de</email>
    </contact>
    <investigator>
      <last_name>Andrej Schmidt, Dr.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Yvonne Bausback, Dr.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Sabine Steiner, PD Dr.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Daniela Branzan, Dr.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Corneliu Popescu, Dr.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Axel Fischer, Dr.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Renaldo Myrselaj, Dr.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>June 2019</verification_date>
  <study_first_submitted>January 21, 2019</study_first_submitted>
  <study_first_submitted_qc>February 14, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">February 15, 2019</study_first_posted>
  <last_update_submitted>June 17, 2019</last_update_submitted>
  <last_update_submitted_qc>June 17, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">June 18, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Leipzig</investigator_affiliation>
    <investigator_full_name>Prof. Dr. Dierk Scheinert</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Aneurysm</mesh_term>
    <mesh_term>Aortic Aneurysm</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

